{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T07:02:44Z","timestamp":1785135764898,"version":"3.55.0"},"posted":{"date-parts":[[2026,7,27]]},"group-title":"In Review","reference-count":70,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["K12TR004415"],"award-info":[{"award-number":["K12TR004415"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001463","name":"American Society of Nephrology","doi-asserted-by":"publisher","award":["KidneyCure Transition to Independence Award"],"award-info":[{"award-number":["KidneyCure Transition to Independence Award"]}],"id":[{"id":"10.13039\/100001463","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,7,23]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  <bold>Background<\/bold>\n                  Chronic kidney disease (CKD) is associated with alterations in gut microbial composition and diversity. Accordingly, dietary fiber has emerged as a promising microbiome-targeted intervention. However, the influence of fiber fermentability and viscosity remains largely understudied.\n                  <bold>Objective<\/bold>\n                  To systematically evaluate the effects of dietary fiber supplementation interventions, classified by viscosity and fermentability, on gut microbial composition in CKD across human and animal studies, and to determine whether these fiber properties influence gut microbiota composition.\n                  <bold>Methods<\/bold>\n                  A systematic search of PubMed, Embase, CINAHL, and Cochrane Library (through February 2026) identified randomized controlled trials and controlled animal studies assessing isolated dietary fiber in CKD. Eligible studies reported gut microbiota composition. Risk of bias was assessed with ROB-2 and SYRCLE, and an overall level of evidence (strong, moderate, weak, or inconclusive) was assigned based on study quality and consistency of findings. Alpha and beta diversity, as well as bacterial taxa changes, were then reported according to these evidence rankings.\n                  <bold>Results<\/bold>\n                  Twenty-two studies (9 human, 13 animal) were included, comprising 236 participants and 274 animals with CKD. Dietary fiber supplementation demonstrated limited and inconsistent effects on gut microbiota composition in human studies. Inulin and resistant starch were associated with weak evidence of changes in beta diversity, but most taxa across phylum and genus levels remained unchanged, often supported by strong or weak evidence depending on the taxonomic level. Modest increases were observed in a small number of genera, including\n                  <italic>Verrucomicrobia, Akkermansia, Clostridium<\/italic>\n                  by inulin, Oscillospiraceae UCG-002, and\n                  <italic>Subdoligranulum<\/italic>\n                  by resistant starch type 2 in human studies, which were not consistent across animal studies. Beta-glucan showed no significant effects on alpha or beta diversity or microbial composition. In contrast, weak evidence from animal studies suggested that beta-glucan may increase alpha diversity.\n                  <bold>Conclusion<\/bold>\n                  Isolated dietary fiber interventions were associated with variable changes in gut microbiota composition in CKD, with limited consistency across human and animal studies, and no clear pattern based solely on fermentability or viscosity. Future studies should use standardized sequencing approaches, harmonized taxonomic reporting, and detailed characterization of fiber properties to clarify whether specific fibers reproducibly modulate microbial community structure.\nThis trial was registered at PROSPERO as CRD42023483468.\n                <\/p>","DOI":"10.21203\/rs.3.rs-10462835\/v1","type":"posted-content","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T06:29:58Z","timestamp":1785133798000},"source":"Crossref","is-referenced-by-count":0,"title":["The effect of dietary fiber based on fermentability and viscosity on the gut microbiome composition in chronic kidney disease: a systematic review of experimental and clinical trials"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1726-0701","authenticated-orcid":false,"given":"Seyedeh Nooshan","family":"Mirmohammadali","sequence":"first","affiliation":[{"name":"Purdue University West Lafayette"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Carrillo","sequence":"additional","affiliation":[{"name":"Iowa State University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6712-9413","authenticated-orcid":false,"given":"Jason B.","family":"Reed","sequence":"additional","affiliation":[{"name":"Purdue University West Lafayette"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1930-703X","authenticated-orcid":false,"given":"Brandon M.","family":"Kistler","sequence":"additional","affiliation":[{"name":"Purdue University West Lafayette"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah E.","family":"Wilson","sequence":"additional","affiliation":[{"name":"Indiana University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6591-942X","authenticated-orcid":false,"given":"Bruce","family":"Hamaker","sequence":"additional","affiliation":[{"name":"Purdue University West Lafayette"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3562-9725","authenticated-orcid":false,"given":"Sharon M.","family":"Moe","sequence":"additional","affiliation":[{"name":"Indiana University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2549-0539","authenticated-orcid":false,"given":"Annabel","family":"Biruete","sequence":"additional","affiliation":[{"name":"Purdue University West Lafayette"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2024) KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int 105:S117\u2013314","journal-title":"Kidney Int"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.kisu.2017.07.007","article-title":"Complications of chronic kidney disease: current state, knowledge gaps, and strategy for action","volume":"7","author":"Bello AK","year":"2017","unstructured":"Bello AK, Alrukhaimi M, Ashuntantang GE, Basnet S, Rotter RC, Douthat WG, Kazancioglu R, K\u00f6ttgen A, Nangaku M, Powe NR et al (2017) Complications of chronic kidney disease: current state, knowledge gaps, and strategy for action. Kidney Int Suppl 7:122\u2013129","journal-title":"Kidney Int Suppl"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"F1211","DOI":"10.1152\/ajprenal.00298.2018","article-title":"Chronic kidney disease and the gut microbiome","volume":"316","author":"Hobby GP","year":"2019","unstructured":"Hobby GP, Karaduta O, Dusio GF, Singh M, Zybailov BL, Arthur JM (2019) Chronic kidney disease and the gut microbiome. Am J Physiol - Ren Physiol 316:F1211\u2013F1217","journal-title":"Am J Physiol - Ren Physiol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/s41581-025-00988-5","article-title":"Microbiota and kidney disease: the road ahead","volume":"21","author":"Bloom PP","year":"2025","unstructured":"Bloom PP, Garrett WS, Penniston KL, Winkler M-KH, Hazen SL, Agudelo J, Suryavanshi M, Babiker A, Dodd D, Fischbach MA et al (2025) Microbiota and kidney disease: the road ahead. Nat Rev Nephrol 21:702\u2013716","journal-title":"Nat Rev Nephrol"},{"key":"ref5","author":"Szeto CC","year":"2026","unstructured":"Szeto CC, Ng JKC (2026) Toxic microbiome and progression of chronic kidney disease: insights from a longitudinal CKD-microbiome study. BMJ Publishing Group; [cited 2026 May 30]; Available from: https:\/\/gut.bmj.com\/content\/75\/5\/847"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/sdi.13030","article-title":"Feeling gutted in chronic kidney disease (CKD): Gastrointestinal disorders and therapies to improve gastrointestinal health in individuals CKD, including those undergoing dialysis","volume":"37","author":"Biruete A","year":"2024","unstructured":"Biruete A, Shin A, Kistler BM, Moe SM (2024) Feeling gutted in chronic kidney disease (CKD): Gastrointestinal disorders and therapies to improve gastrointestinal health in individuals CKD, including those undergoing dialysis. Semin Dial 37:334\u2013349","journal-title":"Semin Dial"},{"key":"ref7","author":"Tsuji K","year":"2024","unstructured":"Tsuji K, Uchida N, Nakanoh H, Fukushima K, Haraguchi S, Kitamura S, Wada J (2024) The Gut\u2013Kidney Axis in Chronic Kidney Diseases. Diagnostics. ;15:21"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1053\/j.gastro.2008.10.080","article-title":"Microbes in Gastrointestinal Health and Disease","volume":"136","author":"NEISH AS","year":"2009","unstructured":"NEISH AS (2009) Microbes in Gastrointestinal Health and Disease. Gastroenterology 136:65\u201380","journal-title":"Gastroenterology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s40168-020-00875-0","article-title":"Microbiome definition re-visited: old concepts and new challenges","volume":"8","author":"Berg G","year":"2020","unstructured":"Berg G, Rybakova D, Fischer D, Cernava T, Verg\u00e8s M-CC, Charles T, Chen X, Cocolin L, Eversole K, Corral GH et al (2020) Microbiome definition re-visited: old concepts and new challenges. Microbiome 8:103","journal-title":"Microbiome"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e0283389","DOI":"10.1371\/journal.pone.0283389","article-title":"Changes in gut microbial community upon chronic kidney disease","volume":"18","author":"Liu W","year":"2023","unstructured":"Liu W, Huang J, Liu T, Hu Y, Shi K, Zhou Y, Zhang N (2023) Changes in gut microbial community upon chronic kidney disease. PLoS ONE 18:e0283389","journal-title":"PLoS ONE"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e18991","DOI":"10.1016\/j.heliyon.2023.e18991","article-title":"Chronic kidney disease and gut microbiota","volume":"9","author":"Amini Khiabani S","year":"2023","unstructured":"Amini Khiabani S, Asgharzadeh M, Samadi Kafil H (2023) Chronic kidney disease and gut microbiota. Heliyon 9:e18991","journal-title":"Heliyon"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.ekir.2025.04.007","article-title":"Gut Microbiome as a Risk Factor for Future CKD","volume":"10","author":"Hellman T","year":"2025","unstructured":"Hellman T, Yeo L-F, Palmu J, Havulinna A, Jousilahti P, Laitinen V, P\u00e4rn\u00e4nen K, Salomaa V, Lahti L, Knight R et al (2025) Gut Microbiome as a Risk Factor for Future CKD. Kidney Int Rep 10:1673\u20131682","journal-title":"Kidney Int Rep"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.2215\/CJN.08200718","article-title":"Gut-Derived Metabolites and Chronic Kidney Disease","volume":"13","author":"Vanholder R","year":"2018","unstructured":"Vanholder R, Glorieux G (2018) Gut-Derived Metabolites and Chronic Kidney Disease. Clin J Am Soc Nephrol CJASN 13:1311\u20131313","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.3390\/microorganisms10122507","article-title":"Dietary Fiber Intake and Gut Microbiota in Human Health","volume":"10","author":"Fu J","year":"2022","unstructured":"Fu J, Zheng Y, Gao Y, Xu W (2022) Dietary Fiber Intake and Gut Microbiota in Human Health. Microorganisms 10:2507","journal-title":"Microorganisms"},{"key":"ref15","first-page":"997","volume":"12","author":"Satam H","year":"2023","unstructured":"Satam H, Joshi K, Mangrolia U, Waghoo S, Zaidi G, Rawool S, Thakare RP, Banday S, Mishra AK, Das G et al (2023) Next-Generation Sequencing Technology: Curr Trends Advancements Biology 12:997","journal-title":"Next-Generation Sequencing Technology: Curr Trends Advancements Biology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41575-026-01176-x","article-title":"The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of gut health","volume":"23","author":"Marco ML","year":"2026","unstructured":"Marco ML, Cunningham M, Bischoff SC, Clarke G, Delzenne N, Lewis JD, Meisel M, Merenstein D, O\u2019Toole PW, Staudacher HM et al (2026) The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of gut health. Nat Rev Gastroenterol Hepatol Nat Publishing Group 23:432\u2013448","journal-title":"Nat Rev Gastroenterol Hepatol Nat Publishing Group"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e0233872","DOI":"10.1371\/journal.pone.0233872","article-title":"Alpha-, beta-, and gamma-diversity of bacteria varies across habitats","volume":"15","author":"Walters KE","year":"2020","unstructured":"Walters KE, Martiny JBH (2020) Alpha-, beta-, and gamma-diversity of bacteria varies across habitats. PLoS ONE 15:e0233872","journal-title":"PLoS ONE"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1186\/s12967-024-05578-w","article-title":"The compositional and functional imbalance of the gut microbiota in CKD linked to disease patterns","volume":"22","author":"Li J","year":"2024","unstructured":"Li J, Shen Y, Yan K, Wang S, Jiao J, Chi H, Zhong J, Dong Y, Wang P (2024) The compositional and functional imbalance of the gut microbiota in CKD linked to disease patterns. J Transl Med 22:773","journal-title":"J Transl Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/ckj\/sfab169","article-title":"Fiber intake and health in people with chronic kidney disease","volume":"15","author":"Su G","year":"2022","unstructured":"Su G, Qin X, Yang C, Sabatino A, Kelly JT, Avesani CM, Carrero JJ (2022) Fiber intake and health in people with chronic kidney disease. Clin Kidney J 15:213\u2013225","journal-title":"Clin Kidney J"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"S367","DOI":"10.1093\/advances\/nmz011","article-title":"Diet and Chronic Kidney Disease","volume":"10","author":"Kramer H","year":"2019","unstructured":"Kramer H (2019) Diet and Chronic Kidney Disease. Adv Nutr 10:S367\u2013S379","journal-title":"Adv Nutr"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3390\/toxins14030183","article-title":"The Role of Dietary Fiber and Gut Microbiome Modulation in Progression of Chronic Kidney Disease","volume":"14","author":"Ranganathan N","year":"2022","unstructured":"Ranganathan N, Anteyi E (2022) The Role of Dietary Fiber and Gut Microbiome Modulation in Progression of Chronic Kidney Disease. Toxins 14:183","journal-title":"Toxins"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3945\/an.115.010546","article-title":"Prebiotics, Fermentable Dietary Fiber, and Health Claims12","volume":"7","author":"Delcour JA","year":"2016","unstructured":"Delcour JA, Aman P, Courtin CM, Hamaker BR, Verbeke K (2016) Prebiotics, Fermentable Dietary Fiber, and Health Claims12. Adv Nutr 7:1\u20134","journal-title":"Adv Nutr"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1080\/10408390500511862","article-title":"Viscosity as related to dietary fiber: a review","volume":"46","author":"Dikeman CL","year":"2006","unstructured":"Dikeman CL, Fahey GC (2006) Viscosity as related to dietary fiber: a review. Crit Rev Food Sci Nutr 46:649\u2013663","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.tem.2020.05.002","article-title":"Discrete Fiber Structures Dictate Human Gut Bacteria Outcomes","volume":"31","author":"Hamaker BR","year":"2020","unstructured":"Hamaker BR, Cantu-Jungles TM (2020) Discrete Fiber Structures Dictate Human Gut Bacteria Outcomes. Trends Endocrinol Metab TEM 31:803\u2013805","journal-title":"Trends Endocrinol Metab TEM"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE\u2019s risk of bias tool for animal studies","volume":"14","author":"Hooijmans CR","year":"2014","unstructured":"Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW (2014) SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol 14:43","journal-title":"BMC Med Res Methodol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"105906","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"88","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE et al (2021) The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Int J Surg Lond Engl 88:105906","journal-title":"Int J Surg Lond Engl"},{"key":"ref27","unstructured":"Cochrane Library About PICO | Cochrane Library [Internet]. [cited 2025 Dec 16]. Available from: https:\/\/www.cochranelibrary.com\/about-pico"},{"key":"ref28","author":"Covidence","unstructured":"Covidence - Better systematic review management [Internet]. Covidence. [cited 2025 Dec 16]. Available from: https:\/\/www.covidence.org\/"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12882-020-01805-w","article-title":"1. The gut microbiota profile of adults with kidney disease and kidney stones: a systematic review of the literature","volume":"21","author":"Stanford J","year":"2020","unstructured":"Stanford J, Charlton K, Stefoska-Needham A, Ibrahim R, Lambert K (2020) 1. The gut microbiota profile of adults with kidney disease and kidney stones: a systematic review of the literature. BMC Nephrol 21:215","journal-title":"BMC Nephrol"},{"key":"ref30","first-page":"l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne JAC","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng H-Y, Corbett MS, Eldridge SM et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ Clin Res ed 366:l4898","journal-title":"BMJ Clin Res ed"},{"key":"ref31","first-page":"512","article-title":"Effect of Dietary Inulin Supplementation on the Gut Microbiota Composition and Derived Metabolites of Individuals Undergoing Hemodialysis: A Pilot Study","volume":"31","author":"Biruete A","year":"2021","unstructured":"Biruete A, Cross T-WL, Allen JM, Kistler BM, de Loor H, Evenepoel P, Fahey GC, Bauer L, Swanson KS, Wilund KR (2021) Effect of Dietary Inulin Supplementation on the Gut Microbiota Composition and Derived Metabolites of Individuals Undergoing Hemodialysis: A Pilot Study. J Ren Nutr Off J Counc Ren Nutr Natl Kidney Found 31:512\u2013522","journal-title":"J Ren Nutr Off J Counc Ren Nutr Natl Kidney Found"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3390\/nu14040805","article-title":"The Effect of \u00df-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial","volume":"14","author":"Ebrahim Z","year":"2022","unstructured":"Ebrahim Z, Proost S, Tito RY, Raes J, Glorieux G, Moosa MR, Blaauw R (2022) The Effect of \u00df-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial. Nutrients 14:805","journal-title":"Nutrients"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"6508","DOI":"10.1039\/C8FO01876F","article-title":"Could resistant starch supplementation improve inflammatory and oxidative stress biomarkers and uremic toxins levels in hemodialysis patients? A pilot randomized controlled trial","volume":"9","author":"Esgalhado M","year":"2018","unstructured":"Esgalhado M, Kemp JA, Azevedo R, Paiva BR, Stockler-Pinto MB, Dolenga CJ, Borges NA, Nakao LS, Mafra D (2018) Could resistant starch supplementation improve inflammatory and oxidative stress biomarkers and uremic toxins levels in hemodialysis patients? A pilot randomized controlled trial. Food Funct 9:6508\u20136516","journal-title":"Food Funct"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.ekir.2020.05.023","article-title":"A Pilot Study on the Effect of Prebiotic on Host-Microbial Co-metabolism in Peritoneal Dialysis Patients","volume":"5","author":"Gao B","year":"2020","unstructured":"Gao B, Alonzo-Palma N, Brooks B, Jose A, Barupal D, Jagadeesan M, Nobakht E, Collins A, Ramezani A, Omar B et al (2020) A Pilot Study on the Effect of Prebiotic on Host-Microbial Co-metabolism in Peritoneal Dialysis Patients. Kidney Int Rep Elsevier 5:1309\u20131315","journal-title":"Kidney Int Rep Elsevier"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00394-021-02669-y","article-title":"Inulin-type prebiotics reduce serum uric acid levels via gut microbiota modulation: a randomized, controlled crossover trial in peritoneal dialysis patients","volume":"61","author":"He S","year":"2022","unstructured":"He S, Xiong Q, Tian C, Li L, Zhao J, Lin X, Guo X, He Y, Liang W, Zuo X et al (2022) Inulin-type prebiotics reduce serum uric acid levels via gut microbiota modulation: a randomized, controlled crossover trial in peritoneal dialysis patients. Eur J Nutr 61:665\u2013677","journal-title":"Eur J Nutr"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1053\/j.jrn.2024.09.005","article-title":"Effects of High Amylose-Resistant Starch on Gut Microbiota and Uremic Toxin Levels in Patients With Stage-G3a-G4 Chronic Kidney Disease: A Randomized Trial","volume":"35","author":"Headley SA","year":"2025","unstructured":"Headley SA, Chapman DJ, Germain MJ, Evans EE, Madsen KL, Miele EM, Kirton K, Loseke J, Cornelius A, Martin B et al (2025) Effects of High Amylose-Resistant Starch on Gut Microbiota and Uremic Toxin Levels in Patients With Stage-G3a-G4 Chronic Kidney Disease: A Randomized Trial. J Ren Nutr Elsevier 35:248\u2013258","journal-title":"J Ren Nutr Elsevier"},{"key":"ref37","first-page":"788","article-title":"Resistant Starch Type-2 Supplementation Does Not Decrease Trimethylamine N-Oxide (TMAO) Plasma Level in Hemodialysis Patients","volume":"41","author":"Kemp JA","year":"2022","unstructured":"Kemp JA, dos Santos HF, de Jesus HE, Esgalhado M, de Paiva BR, Azevedo R, Stenvinkel P, Bergman P, Lindholm B, Ribeiro-Alves M et al (2022) Resistant Starch Type-2 Supplementation Does Not Decrease Trimethylamine N-Oxide (TMAO) Plasma Level in Hemodialysis Patients. J Am Nutr Assoc Taylor Francis 41:788\u2013795","journal-title":"J Am Nutr Assoc Taylor Francis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/hdi.12753","article-title":"Amylose resistant starch (HAM-RS2) supplementation increases the proportion of Faecalibacterium bacteria in end-stage renal disease patients: Microbial analysis from a randomized placebo-controlled trial","volume":"23","author":"Laffin MR","year":"2019","unstructured":"Laffin MR, Tayebi Khosroshahi H, Park H, Laffin LJ, Madsen K, Kafil HS, Abedi B, Shiralizadeh S, Vaziri ND (2019) Amylose resistant starch (HAM-RS2) supplementation increases the proportion of Faecalibacterium bacteria in end-stage renal disease patients: Microbial analysis from a randomized placebo-controlled trial. Hemodial Int Int Symp Home Hemodial 23:343\u2013347","journal-title":"Hemodial Int Int Symp Home Hemodial"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.3390\/nu11123006","article-title":"Effect of Low-Protein Diet and Inulin on Microbiota and Clinical Parameters in Patients with Chronic Kidney Disease","volume":"11","author":"Lai S","year":"2019","unstructured":"Lai S, Molfino A, Testorio M, Perrotta AM, Currado A, Pintus G, Pietrucci D, Unida V, La Rocca D, Biocca S et al (2019) Effect of Low-Protein Diet and Inulin on Microbiota and Clinical Parameters in Patients with Chronic Kidney Disease. Nutrients 11:3006","journal-title":"Nutrients"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/ajcn\/nqz337","article-title":"Inulin-type fructan intervention restricts the increase in gut microbiome\u2013generated indole in patients with peritoneal dialysis: a randomized crossover study","volume":"111","author":"Li L","year":"2020","unstructured":"Li L, Xiong Q, Zhao J, Lin X, He S, Wu N, Yao Y, Liang W, Zuo X, Ying C (2020) Inulin-type fructan intervention restricts the increase in gut microbiome\u2013generated indole in patients with peritoneal dialysis: a randomized crossover study. Am J Clin Nutr 111:1087\u20131099","journal-title":"Am J Clin Nutr"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"569402","DOI":"10.3389\/fphar.2020.569402","article-title":"10. The Effects of Gum Acacia on the Composition of the Gut Microbiome and Plasma Levels of Short-Chain Fatty Acids in a Rat Model of Chronic Kidney Disease","volume":"11","author":"Al-Asmakh M","year":"2020","unstructured":"Al-Asmakh M, Sohail MU, Al-Jamal O, Shoair BM, Al-Baniali AY, Bouabidi S, Nasr S, Bawadi H (2020) 10. The Effects of Gum Acacia on the Composition of the Gut Microbiome and Plasma Levels of Short-Chain Fatty Acids in a Rat Model of Chronic Kidney Disease. Front Pharmacol 11:569402","journal-title":"Front Pharmacol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.3390\/nu15153363","article-title":"3. The Usefulness of Resistant Maltodextrin and Chitosan Oligosaccharide in Management of Gut Leakage and Microbiota in Chronic Kidney Disease","volume":"15","author":"Anegkamol W","year":"2023","unstructured":"Anegkamol W, Kamkang P, Hunthai S, Kaewwongse M, Taweevisit M, Chuaypen N, Rattanachaisit P, Dissayabutra T (2023) 3. The Usefulness of Resistant Maltodextrin and Chitosan Oligosaccharide in Management of Gut Leakage and Microbiota in Chronic Kidney Disease. Nutrients 15:3363","journal-title":"Nutrients"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"e10837","DOI":"10.1002\/jbm4.10837","article-title":"2. The Dietary Fiber Inulin Slows Progression of Chronic Kidney Disease-Mineral Bone Disorder (CKD-MBD) in a Rat Model of CKD","volume":"7","author":"Biruete A","year":"2023","unstructured":"Biruete A, Chen NX, Metzger CE, Srinivasan S, O\u2019Neill K, Fallen PB, Fonseca A, Wilson HE, de Loor H, Evenepoel P et al (2023) 2. The Dietary Fiber Inulin Slows Progression of Chronic Kidney Disease-Mineral Bone Disorder (CKD-MBD) in a Rat Model of CKD. JBMR Plus 7:e10837","journal-title":"JBMR Plus"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"e12029","DOI":"10.14814\/phy2.12029","article-title":"1. Galacto\u2010oligosaccharides attenuate renal injury with microbiota modification","volume":"2","author":"Furuse SU","year":"2014","unstructured":"Furuse SU, Ohse T, Jo-Watanabe A, Shigehisa A, Kawakami K, Matsuki T, Chonan O, Nangaku M (2014) 1. Galacto\u2010oligosaccharides attenuate renal injury with microbiota modification. Physiol Rep 2:e12029","journal-title":"Physiol Rep"},{"key":"ref45","author":"Hu D","unstructured":"Hu D, Liu W, Yu W, Huang L, Ji C, Liu X, Lu Z 13. Psyllium seed husk regulates the gut microbiota and improves mucosal barrier injury in the colon to attenuate renal injury in 5\/6 nephrectomy rats. Ren Fail 45:2197076"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/jn\/nxy008","article-title":"11. Dietary Fermentable Fibers Attenuate Chronic Kidney Disease in Mice by Protecting the Intestinal Barrier","volume":"148","author":"Hung TV","year":"2018","unstructured":"Hung TV, Suzuki T (2018) 11. Dietary Fermentable Fibers Attenuate Chronic Kidney Disease in Mice by Protecting the Intestinal Barrier. J Nutr 148:552\u2013561","journal-title":"J Nutr"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"F857","DOI":"10.1152\/ajprenal.00513.2015","article-title":"6. Resistant starch alters gut microbiome and metabolomic profiles concurrent with amelioration of chronic kidney disease in rats","volume":"310","author":"Kieffer DA","year":"2016","unstructured":"Kieffer DA, Piccolo BD, Vaziri ND, Liu S, Lau WL, Khazaeli M, Nazertehrani S, Moore ME, Marco ML, Martin RJ et al (2016) 6. Resistant starch alters gut microbiome and metabolomic profiles concurrent with amelioration of chronic kidney disease in rats. Am J Physiol - Ren Physiol 310:F857\u2013F871","journal-title":"Am J Physiol - Ren Physiol"},{"key":"ref48","author":"Lakshmanan AP","year":"2021","unstructured":"Lakshmanan AP, Al Za\u2019abi M, Ali BH, Terranegra A (2021) 9. The influence of the prebiotic gum acacia on the intestinal microbiome composition in rats with experimental chronic kidney disease. Biomed Pharmacother ;133:110992"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"106367","DOI":"10.1016\/j.phrs.2022.106367","article-title":"4. Inulin-type fructans change the gut microbiota and prevent the development of diabetic nephropathy","volume":"183","author":"Luo L","year":"2022","unstructured":"Luo L, Luo J, Cai Y, Fu M, Li W, Shi L, Liu J, Dong R, Xu X, Tu L et al (2022) 4. Inulin-type fructans change the gut microbiota and prevent the development of diabetic nephropathy. Pharmacol Res 183:106367","journal-title":"Pharmacol Res"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3164\/jcbn.20-46","article-title":"12. Effects of dietary fiber on vascular calcification by repetitive diet-induced fluctuations in plasma phosphorus in early-stage chronic kidney disease rats","volume":"67","author":"Tani M","year":"2020","unstructured":"Tani M, Tanaka S, Takamiya K, Kato Y, Harata G, He F, Sakaue M, Ito M (2020) 12. Effects of dietary fiber on vascular calcification by repetitive diet-induced fluctuations in plasma phosphorus in early-stage chronic kidney disease rats. J Clin Biochem Nutr 67:283\u2013289","journal-title":"J Clin Biochem Nutr"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"875060","DOI":"10.3389\/fnut.2022.875060","article-title":"8.Oat \u03b2 Glucan Ameliorates Renal Function and Gut Microbiota in Diabetic Rats","volume":"9","author":"Wang R","year":"2022","unstructured":"Wang R, Zhang Z, Aihemaitijiang S, Ye C, Halimulati M, Huang X, Qin H (2022) 8.Oat \u03b2 Glucan Ameliorates Renal Function and Gut Microbiota in Diabetic Rats. Front Nutr 9:875060","journal-title":"Front Nutr"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1800014","DOI":"10.1002\/mnfr.201800014","article-title":"7. Effects of Prebiotic Fiber Xylooligosaccharide in Adenine-Induced Nephropathy in Mice","volume":"62","author":"Yang J","year":"2018","unstructured":"Yang J, Li Q, Henning SM, Zhong J, Hsu M, Lee R, Long J, Chan B, Nagami GT, Heber D et al (2018) 7. Effects of Prebiotic Fiber Xylooligosaccharide in Adenine-Induced Nephropathy in Mice. Mol Nutr Food Res 62:1800014","journal-title":"Mol Nutr Food Res"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"e0199274","DOI":"10.1371\/journal.pone.0199274","article-title":"5. Metaproteomics reveals potential mechanisms by which dietary resistant starch supplementation attenuates chronic kidney disease progression in rats","volume":"14","author":"Zybailov BL","year":"2019","unstructured":"Zybailov BL, Glazko GV, Rahmatallah Y, Andreyev DS, McElroy T, Karaduta O, Byrum SD, Orr L, Tackett AJ, Mackintosh SG et al (2019) 5. Metaproteomics reveals potential mechanisms by which dietary resistant starch supplementation attenuates chronic kidney disease progression in rats. PLoS ONE 14:e0199274","journal-title":"PLoS ONE"},{"key":"ref54","first-page":"1","article-title":"Microbiota and kidney disease: the road ahead","author":"Bloom PP","year":"2025","unstructured":"Bloom PP, Garrett WS, Penniston KL, Winkler M-KH, Hazen SL, Agudelo J, Suryavanshi M, Babiker A, Dodd D, Fischbach MA et al (2025) Microbiota and kidney disease: the road ahead. Nat Rev Nephrol Nat Publishing Group ; ;1\u201315","journal-title":"Nat Rev Nephrol Nat Publishing Group"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/s41564-026-02259-w","article-title":"Host factors dictate gut microbiome alterations in chronic kidney disease more strongly than kidney function","volume":"11","author":"Krukowski H","year":"2026","unstructured":"Krukowski H, Valkenburg S, Vich Vila A, Maciel LF, V\u00e1zquez-Castellanos JF, Gryp T, Joossens M, Van Biesen W, Verbeke F, Derrien M et al (2026) Host factors dictate gut microbiome alterations in chronic kidney disease more strongly than kidney function. Nat Microbiol Nat Publishing Group 11:664\u2013677","journal-title":"Nat Microbiol Nat Publishing Group"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.0030-1299.2004.12685.x","article-title":"Does functional redundancy exist?","volume":"104","author":"Loreau M","year":"2004","unstructured":"Loreau M (2004) Does functional redundancy exist? Oikos 104:606\u2013611","journal-title":"Oikos"},{"key":"ref57","first-page":"S30","article-title":"Targeting the Gut Microbiota in Kidney Disease: The Future in Renal Nutrition and Metabolism","volume":"33","author":"Lambert K","year":"2023","unstructured":"Lambert K, Rinninella E, Biruete A, Sumida K, Stanford J, Raoul P, Mele MC, Wang AY-M, Mafra D (2023) Targeting the Gut Microbiota in Kidney Disease: The Future in Renal Nutrition and Metabolism. J Ren Nutr Off J Counc Ren Nutr Natl Kidney Found 33:S30\u2013S39","journal-title":"J Ren Nutr Off J Counc Ren Nutr Natl Kidney Found"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1053\/j.jrn.2022.12.004","article-title":"3. Targeting the Gut Microbiota in Kidney Disease: The Future in Renal Nutrition and Metabolism","volume":"33","author":"Lambert K","year":"2023","unstructured":"Lambert K, Rinninella E, Biruete A, Sumida K, Stanford J, Raoul P, Mele MC, Wang AY-M, Mafra D (2023) 3. Targeting the Gut Microbiota in Kidney Disease: The Future in Renal Nutrition and Metabolism. J Ren Nutr Elsevier 33:S30\u2013S39","journal-title":"J Ren Nutr Elsevier"},{"key":"ref59","first-page":"155","volume-title":"The Role of Gut Microbiota and Diet on Uremic Retention Solutes Production in the Context of Chronic Kidney Disease","author":"Koppe L","year":"2018","unstructured":"Koppe L, Fouque D, Soulage CO (2018) The Role of Gut Microbiota and Diet on Uremic Retention Solutes Production in the Context of Chronic Kidney Disease, vol 10. Toxins Multidisciplinary Digital Publishing Institute, p 155"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.3390\/nu18091341","article-title":"Dietary Fibre and Chronic Kidney Disease: A Systematic Review of Effects on Inflammation, Uraemic Toxins, Nutritional Status, Kidney Function, and Gut\u2013Liver\u2013Kidney Axis Mechanisms","volume":"18","author":"Mojak AG","year":"2026","unstructured":"Mojak AG, Bronkowska M (2026) Dietary Fibre and Chronic Kidney Disease: A Systematic Review of Effects on Inflammation, Uraemic Toxins, Nutritional Status, Kidney Function, and Gut\u2013Liver\u2013Kidney Axis Mechanisms. Nutrients 18:1341","journal-title":"Nutrients"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.14336\/AD.2022.0104","article-title":"Functions of Gut Microbiota Metabolites, Current Status and Future Perspectives","volume":"13","author":"Liu J","year":"2022","unstructured":"Liu J, Tan Y, Cheng H, Zhang D, Feng W, Peng C (2022) Functions of Gut Microbiota Metabolites, Current Status and Future Perspectives. Aging Dis 13:1106\u20131126","journal-title":"Aging Dis"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3390\/toxins13020142","article-title":"Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets","volume":"13","author":"Lim YJ","year":"2021","unstructured":"Lim YJ, Sidor NA, Tonial NC, Che A, Urquhart BL (2021) Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets. Toxins 13:142","journal-title":"Toxins"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1801912\/full","author":"Guan R","year":"2026","unstructured":"Guan R, Peng J, Gu Q, Xu J, Zhang J, Adamu H, Yang Q, Wang L, Cao G (2026) The gut-kidney axis in chronic kidney disease: a vicious cycle of microbial dysbiosis and uremic toxin accumulation. Front Immunol [Internet] Frontiers; [cited 2026 June 9];17. Available from: https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/10.3389\/fimmu.2026.1801912\/full"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ki.2012.345","article-title":"Chronic kidney disease alters intestinal microbial flora","volume":"83","author":"Vaziri ND","year":"2013","unstructured":"Vaziri ND, Wong J, Pahl M, Piceno YM, Yuan J, DeSantis TZ, Ni Z, Nguyen T-H, Andersen GL (2013) Chronic kidney disease alters intestinal microbial flora. Kidney Int 83:308\u2013315","journal-title":"Kidney Int"},{"key":"ref65","first-page":"1862","volume-title":"Chronic Kidney Disease, Gut Dysbiosis, and Constipation: A Burdensome Triplet","author":"Ikee R","year":"2020","unstructured":"Ikee R, Sasaki N, Yasuda T, Fukazawa S (2020) Chronic Kidney Disease, Gut Dysbiosis, and Constipation: A Burdensome Triplet, vol 8. Microorganisms Multidisciplinary Digital Publishing Institute, p 1862"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/jorc.12373","article-title":"Gastrointestinal symptom burden and dietary intake in patients with chronic kidney disease","volume":"47","author":"Meade A","year":"2021","unstructured":"Meade A, Le Leu R, Watson N, Jesudason S, Clayton P, Faull R, McDonald S, Trimingham C (2021) Gastrointestinal symptom burden and dietary intake in patients with chronic kidney disease. J Ren Care 47:234\u2013241","journal-title":"J Ren Care"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11892-017-0841-z","article-title":"Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease","volume":"17","author":"Sabatino A","year":"2017","unstructured":"Sabatino A, Regolisti G, Cosola C, Gesualdo L, Fiaccadori E (2017) Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease. Curr Diab Rep 17:16","journal-title":"Curr Diab Rep"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"892232","DOI":"10.3389\/fcimb.2022.892232","article-title":"Circulating Microbiota in Cardiometabolic Disease","volume":"12","author":"Sumida K","year":"2022","unstructured":"Sumida K, Han Z, Chiu C-Y, Mims TS, Bajwa A, Demmer RT, Datta S, Kovesdy CP, Pierre JF (2022) Circulating Microbiota in Cardiometabolic Disease. Front Cell Infect Microbiol 12:892232","journal-title":"Front Cell Infect Microbiol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1186\/s12967-023-04455-2","article-title":"The gut microbiome tango in the progression of chronic kidney disease and potential therapeutic strategies","volume":"21","author":"Tang Z","year":"2023","unstructured":"Tang Z, Yu S, Pan Y (2023) The gut microbiome tango in the progression of chronic kidney disease and potential therapeutic strategies. J Transl Med 21:689","journal-title":"J Transl Med"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1136\/gutjnl-2019-319766","article-title":"Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents","volume":"69","author":"Wang X","year":"2020","unstructured":"Wang X, Yang S, Li S, Zhao L, Hao Y, Qin J, Zhang L, Zhang C, Bian W, Zuo L et al (2020) Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents. Gut 69:2131\u20132142","journal-title":"Gut"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10462835\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10462835\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T06:30:10Z","timestamp":1785133810000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10462835\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":70,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-10462835\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,7,27]]},"subtype":"preprint"}}